Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.

Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS
Clin Cancer Res. 2004 10 (1 Pt 1): 136-43

PMID: 14734462 · DOI:10.1158/1078-0432.ccr-0373-3

MeSH Terms (25)

Adenocarcinoma Adenocarcinoma, Bronchiolo-Alveolar Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Disease Progression ErbB Receptors Female Follow-Up Studies Humans Immunoenzyme Techniques Lung Neoplasms Male Middle Aged Neoplasm Recurrence, Local Neoplasm Staging Phosphorylation Prognosis Receptor, ErbB-2 Retrospective Studies Risk Factors Survival Rate Transforming Growth Factor alpha

Connections (1)

This publication is referenced by other Labnodes entities:

Links